Background Image
Table of Contents Table of Contents
Previous Page  13 / 72 Next Page
Information
Show Menu
Previous Page 13 / 72 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016

AFRICA

67

the controls was estimated at 1.5

×

the total number of patients

(

±

five patients).

PPCM was defined according to the recommendations of

the Heart Failure Association of the European Society of

Cardiology working group on PPCM, and left ventricular (LV)

systolic dysfunction was defined as LV ejection fraction

<

50%.

7

At the study centres, physicians in the Internal Medicine,

and Obstetrics and Gynaecology Departments were approached

and requested to refer all patients with suspected PPCM to the

principal investigator (PI) for further evaluation. Patients were

then interviewed, clinically evaluated and recruited consecutively.

Hospital in-patients with PPCM were clinically assessed and

underwent investigations within the first 48 hours of admission.

Demographic data, relevant aspects of the history and

physical signs, results of investigations, co-morbid conditions,

and complications were included in a detailed questionnaire.

Baseline levels of serum urea, electrolytes and creatinine were

carried out in the laboratories of AKTH, while 12-lead ECGs

at rest, and transthoracic echocardiograms (for PPCM patients

only) were all carried out by the PI at the study sites, according to

standard recommendations.

8

The echocardiographic examination

was performed using a Sonoscape S8 Doppler ultrasound

(Shenzhen, China, 2010) and the ECG was recorded using a

Mindray DECG-03A digital electrocardiograph (Shenzhen,

China, 2008).

8,9

All ECG recordings were studied and interpreted by the

investigators in the standard fashion, and ECG intervals/

durations were measured using manual callipers.

10,11

The controls

were evaluated using the same protocol as the patients, including

the ECGs, but an echocardiogram was not performed.

Statistical analysis

Frequencies, mean, median and inter-quartile ranges were used

to describe patients’ characteristics. Chi-square, Fisher’s exact

probability, Student’s

t

- and Mann–Whitney

U

-tests were used

to compare categorical and continuous variables as appropriate.

Binary logistic regression models were used to determine

predictors of PPCM among the ECG variables, and values were

expressed as odds ratios (OR) and 95% confidence intervals (CI).

Pearson’s correlation coefficient and linear regression models

were used to further assess relationships between variables of

interest.

A simple score assigning 1 to each identified independent

ECG predictor was composed and its accuracy in predicting

PPCM was determined using the area under the receiver

operating characteristics (ROC) curve (AUC), and AUC

>

0.75

was considered satisfactory. A

p

-value

<

0.05 was considered

statistically significant. The statistical analysis was carried out

using SPSS version 16.0 software.

Results

A total of 54 PPCM and 77 controls satisfied all the inclusion

criteria and were consecutively recruited. PPCM patients were

recruited at the time of confirmation of diagnosis, when specific

heart failure treatment was also commenced.

The baseline characteristics of the subjects are presented

in Table 1. The mean age, body mass index (BMI), systolic

(SBP) and diastolic blood pressure (DBP), and prevalence of

pregnancy-induced hypertension were not significantly different

between the two groups (

p

>

0.05). However, mean serum level of

creatinine was higher (

p

=

0.045), and mean serum sodium and

potassium levels were significantly lower (

p

=

0.009 and

<

0.001

respectively) in patients compared to controls.

ECG findings are presented in Table 2. All subjects were

in sinus rhythm, and ectopic beats and PR interval were

not significantly different (

p

>

0.05) between the two groups.

However, patients had significantly faster heart rates, broader

QRS durations, prolonged QTc intervals, and more frequent

tachycardia and ST–T-wave abnormalities (T-wave inversion

with or without ST-segment depression in all leads except aVR,

V1 and V2) than the controls (

p

<

0.004 for all comparisons).

ECG predictors of PPCM

The results of the logistic regression models are presented

in Table 3. In the univariate analysis, heart rate, ST–T-wave

abnormalities, and QRS and QTc durations were all predictors

of PPCM (

p

≤ 0.003). In addition, heart rate

<

100 beats/min

reduced the risk of having PPCM by 89.7% (

p

<

0.001). The

presence of ST–T-wave abnormalities increased the odds of

PPCM almost 12-fold (

p

<

0.001), while QRS duration

>

110

ms and QTc duration

>

460 ms increased the odds 5.2-fold (

p

<

0.001) and 9.5-fold (

p

<

0.001), respectively.

Stepwise multivariate regression analyses were then carried

out to control for confounding factors. In the initial model,

including heart rate, ST–T-wave abnormalities, QRS duration

Table 1. Baseline characteristics of PPCM patients and controls

PPCM

patients

(

n

=

54)

Controls

(

n

=

77)

p

-value

Mean age (years)

26.6

±

6.7 25.7

±

5.7 0.450

Body mass index (kg/m

2

)

21.6

±

4.3 21.8

±

4.3 0.836

Systolic BP (mmHg)

119

±

24 123

±

16 0.293

Diastolic BP(mmHg)

86

±

18 82

±

12 0.099

Pregnancy-induced hypertension,

n

(%) 16 (41.0)

14 (28)

0.197

Serum creatinine (µmol/l)

93.2

±

67.1 74.7

±

19.3 0.045*

Serum sodium (mmol/l)

136.9

±

5.9 139.6

±

4.4 0.009*

Serum potassium (mmol/l)

3.9

±

0.8 4.6

±

0.7

<

0.001*

*

p

-value statistically significant; values are expressed as means

±

standard

deviations or as numbers with percentages in parentheses.

Table 2. ECG features of PPCM patients and controls

PPCM patients

(

n

=

54)

Controls

(

n

=

77)

p

-value

Sinus rhythm,

n

(%)

54 (100)

77 (100)

Premature ventricular or

atrial extrasystoles,

n

(%)

5 (9.3)

4 (5.2)

0.365

Heart rate, beats/min

111

±

16

90

±

16

<

0.001*

Tachycardia,

n

(%)

36 (66.7)

17 (22.1)

<

0.001*

QRS duration (ms)

109.9

±

23.6

98.6

±

12.8

0.004*

QRS duration

110 ms

19 (35.2)

8 (10.4)

0.001*

QTc duration (ms)

445.0

±

34.2

421.2

±

18.9

<

0.001*

QTc duration

460 ms

12 (22.2)

3 (3.9)

0.001*

PR interval (ms)

148.1

±

20.4

149.1

±

21.1

0.799

ST–T-wave abnormalities

37 (68.5)

13 (16.9)

<

0.001*

*

p

-value statistically significant; values are expressed as means

±

standard

deviations or as numbers with percentages in parentheses.